Trial intelligence / Profile preview

Botox for Trismus in Head & Neck Cancer

NCT06734598Phase 4Recruiting

Sponsor
National Taiwan University Hospital
Start
Dec 2024
Primary completion
Nov 2025
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of botulinum toxin type A in trismus, sponsored by National Taiwan University Hospital. Started Dec 2024; status: recruiting.

02

Drugs

botulinum toxin type A
03

Conditions

trismus

Beyond the preview

Go deeper on NCT06734598.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06734598.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call